SPGZ yields 0.01% · JNJ yields 2.13%● Live data
📍 JNJ pulled ahead of the other in Year 4
Combined, SPGZ + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of SPGZ + JNJ for your $10,000?
Spectrum Group International, Inc., together with its subsidiaries, operates as a trading and collectibles network in the United States and Europe. The company operates in two segments, Trading and Collectibles. The Trading segment is engaged in the trade of metals, including gold, silver, platinum, and palladium for storage and delivery in the form of coins, bars, wafers, and grain; and providing financing, consignment, hedging, and various customized financial programs. This segment also offers loans on precious metals and rare coins collateral to coin dealers, collectors, and investors; promotes A-Mark bullion products; and offers storage solutions to institutions, dealers, and consumers. Its customers include sovereign mints and mines, manufacturers and fabricators, refiners, coin and bullion dealers, banks and other financial institutions, commodity brokerage houses, industrial users of precious metals, jewelers, private investors, investment advisors, and collectors. The Collectibles segment offers coins, paper currency, and rare and fine vintage wines. This segment sells its products to collectors and dealers through traditional live auctions, Internet and telephone auctions, and retail sale. The company was founded in 1981 and is headquartered in Irvine, California.
Full SPGZ Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.